Retraction
A Randomized Phase II Study of Everolimus for Advanced Pancreatic Neuroendocrine Tumors in Chinese Patients
Paper Information
Record ID:
3640
Journal:
Publication Date:
November 14, 2014
Retraction Date:
July 21, 2015
(10.3 years years ago)
Subjects:
Institutions:
- Department of Gastroenterology, Shenzhen Municipal People’s Hospital, Jinan University of Medical Sciences, Shenzhen, China
- Department of General Surgery, Shenzhen Children’s Hospital, Shenzhen, China
- Translational Medicine Center, Laboratory of Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (12)
12
Total Citations9
Post-Retraction(75.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
7
After 2+ years
2185
Days since retraction (latest)
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Jul 2021
2185 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Aug 2019
1484 days after retraction
Paper citing Vemurafenib in Multiple Nonmelanoma Cancers with B...
Unknown Authors
Unknown Journal
Published: Feb 2019
1291 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Oct 2018
1168 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Sep 2018
1138 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Feb 2018
951 days after retraction
Paper citing The Efficacy of the Novel Dual PI3-Kinase/mTOR Inh...
Unknown Authors
Unknown Journal
Published: Feb 2018
931 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Jul 2016
359 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Apr 2016
270 days after retraction
Paper citing A Randomized Phase II Study of Everolimus for Adva...
Unknown Authors
Unknown Journal
Published: Jun 2015
26 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
10.3 years
Open Access:
Yes
Last Checked:
Never